These findings identify a gut microbiota-BCAA-propionate axis that may influence neurodegenerative processes through modulation of PI3K/Akt/mTORC1 signaling, highlighting microbial metabolites as potential modulators of gut-brain communication in PD.
Key Findings
Results
PD patients exhibited gut dysbiosis, reduced BCAA levels, and depletion of SCFA-producing microbial taxa compared to controls.
Clinical observations in PD patients were combined with mechanistic studies to establish baseline differences in gut microbiota composition
Gut microbiota composition was profiled using 16S rRNA sequencing
Fecal and serum metabolites were analyzed by GC-MS to quantify BCAA and SCFA levels
SCFA-producing bacterial taxa were specifically depleted in PD patients
Results
BCAA supplementation in MPTP-induced PD mice partially restored microbial composition and enhanced predicted propionate biosynthesis pathways.
Studies were conducted in MPTP-induced PD mouse models
16S rRNA sequencing was used to profile gut microbiota composition changes following BCAA supplementation
Predicted propionate biosynthesis pathways were enhanced following BCAA supplementation
The restoration of microbial composition was partial, not complete
Results
Propionate administration improved motor performance and preserved dopaminergic neurons in MPTP-induced PD mice.
Neurobehavioral performance was evaluated using standard motor assays in vivo
Dopaminergic neuron integrity was assessed using immunohistochemistry
Propionate administration mitigated neuroinflammatory responses in vivo
Reduced apoptosis was observed both in vivo (mouse model) and in vitro (MPP+-treated SH-SY5Y neuronal cells)
Results
Propionate restored PI3K/Akt/mTORC1 pathway activation, upregulated Bcl-2, and suppressed cleaved caspase-3 in dopaminergic neurons.
Propionate restored phosphorylation of PI3K, Akt, and mTORC1
Bcl-2, an anti-apoptotic protein, was upregulated following propionate treatment
Cleaved caspase-3, a pro-apoptotic marker, was suppressed following propionate treatment
These effects were assessed via Western blotting and cellular assays
Apoptosis-related markers were evaluated using immunohistochemistry and Western blotting
Results
The neuroprotective effects of propionate were abolished by pharmacological PI3K inhibition, confirming PI3K/Akt/mTORC1 pathway dependence.
Pharmacological inhibition of PI3K was used to confirm mechanistic involvement of the pathway
All propionate-mediated effects on Bcl-2 upregulation and caspase-3 suppression were abolished upon PI3K inhibition
Studies were conducted in MPP+-treated SH-SY5Y neuronal cells in vitro
Results confirmed that the PI3K/Akt/mTORC1 axis is required for propionate's neuroprotective effects
Background
Altered gut microbiota composition and reduced levels of neuroprotective microbial metabolites such as SCFAs have been reported in patients with PD.
The gut-brain axis is increasingly implicated in PD pathogenesis
SCFAs, particularly propionate, are considered neuroprotective microbial metabolites
BCAAs are essential nutrients influenced by microbial metabolism
BCAAs may contribute to neuroimmune regulation through SCFA production and modulation of PI3K/Akt/mTORC1 signaling
What This Means
This research suggests that there is a communication pathway between gut bacteria and the brain that may play an important role in Parkinson's disease (PD). The study found that PD patients have disrupted gut bacterial communities with fewer bacteria that produce beneficial compounds called short-chain fatty acids (SCFAs), and also have lower levels of branched-chain amino acids (BCAAs), which are nutrients found in protein-rich foods. In mouse models of PD, supplementing with BCAAs helped partially restore the gut bacterial communities and boosted the production of a specific SCFA called propionate.
When propionate was given directly to PD mice and to brain cells treated with a Parkinson's-inducing toxin, it protected dopamine-producing neurons from dying, reduced brain inflammation, and improved movement abilities. At the molecular level, propionate worked by reactivating a specific cell survival signaling chain (PI3K/Akt/mTORC1), turning on protective proteins (Bcl-2) and turning off cell death proteins (caspase-3). When researchers chemically blocked the first step of this signaling chain, all of propionate's protective effects disappeared, confirming that this pathway is essential.
This research suggests that the gut microbiome, dietary amino acids, and brain health are connected through microbial production of propionate. The findings point to the gut-brain axis—specifically the bacteria that produce propionate—as a potential target for understanding and possibly influencing the progression of Parkinson's disease. This does not mean that taking BCAA supplements or propionate is a treatment for PD, but it does highlight microbial metabolites as a promising area for future research into neuroprotective strategies.
Mi N, Ma L, Zhao J, Bu X, Xu J, Fu J, et al.. (2026). Branched-chain amino acids alleviate Parkinson's neurodegeneration via microbial propionate-dependent restoration of the PI3K/Akt/mTORC1 axis.. Molecular immunology. https://doi.org/10.1016/j.molimm.2026.05.003